Journal of Nutrition Animal Diets/Enrichment Products...

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torres, N.
Right arrow Articles by Tovar, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torres, N.
Right arrow Articles by Tovar, A. R.

The Journal of Nutrition Vol. 128 No. 8 August 1998, pp. 1368-1375

Dietary Protein Level Regulates Expression of the Mitochondrial Branched-Chain Aminotransferase in Rats1,2

Nimbe Torres, Gabriel López, Soledad De Santiago, Susan M. Hutson*, and Armando R. Tovar3

Departamento de Fisiología de la Nutrición, Instituto Nacional de Nutrición, México D.F., 14000, Mexico and * Department of Biochemistry, Wake Forest University Medical Center, Winston-Salem, NC 27157

    ABSTRACT
Abstract
Introduction
Methods
Results
Discussion
References

The first step in the degradation of branched-chain amino acids (BCAA) is transamination catalyzed by the branched-chain aminotransferase (BCAT), which is located in extrahepatic tissues. Studies of the effect of dietary protein on BCAT activity have given contradictory results. Therefore, we established the levels of BCAT activity and mitochondrial BCAT (BCATm) mRNA expression in different organs and tissues of rats. We then determined the effect of different levels of dietary protein in well-nourished rats, the effect of feeding a 0.5% casein diet for 5 wk (protein-malnourished rats) and nutritional rehabilitation of these rats with different levels of dietary protein on BCAT activity and BCATm mRNA expression in selected tissues. Finally, the response of tissue BCAT activity and BCATm mRNA levels in rats fed a 10% casein diet and injected with glucagon (4 d) or hydrocortisone (7 d) was determined. The highest concentration of BCATm mRNA was found in stomach, followed by kidney, heart, muscle, brain, skin and lung. Low levels were found in intestine, and no BCATm mRNA was detectable in liver. Although BCAT activity was significantly higher in muscle, kidney and brain from rats adapted to consume a 50% casein diet for 7 h/d for 10 d than in rats fed 6, 18 or 35% casein diets, only muscle had significantly higher levels of BCATm mRNA. In protein-malnourished rats, BCAT activity and BCATm mRNA expression in kidney, muscle and heart were not different from those of rats with free access to an 18% casein diet. Nutritional rehabilitation of the protein-malnourished rats with 50% casein for 21 d significantly increased the BCAT activity and BCATm mRNA expression in muscle. Neither hydrocortisone nor glucagon injection affected BCAT activity or BCATm mRNA concentrations in rat kidney, muscle or heart. We conclude that the nutritional regulation of BCATm is extrahepatic, tissue specific and may involve transcriptional and post-translational mechanisms.

KEY WORDS: branched-chain aminotransferase · hormones · malnutrition · protein · rats

    INTRODUCTION
Abstract
Introduction
Methods
Results
Discussion
References

The first step in the degradation of the branched-chain amino acids (BCAA),4 leucine, valine and isoleucine, is transamination of BCAA catalyzed by the branched-chain aminotransferase (BCAT; EC 2.6.1.42). This enzyme can accept an amino group from any of the three branched-chain amino acids and transfer it to alpha -ketoglutarate or any of the three corresponding branched-chain alpha -keto acids. The branched-chain alpha -keto acids can be reaminated in the mitochondria to their respective amino acids (Hutson et al 1988, Torres et al. 1993) or irreversibly decarboxylated by the branched-chain alpha -keto acid dehydrogenase enzyme complex. The decarboxylation products are isovaleryl-CoA, alpha -methylbutyryl-CoA and isobutyryl-CoA for valine, isoleucine and leucine, respectively.

The BCAT isoenzymes, which are separate gene products (Bledsoe et al. 1997, Hutson et al. 1995), are specific for the three branched-chain amino acids (Hall et al. 1993, Ichihara and Koyama 1966, Taylor and Jenkins 1966) and are distributed in the cytosol (BCATc) or the mitochondria (BCATm) (Hutson 1988) with the highest specific activity in pancreas, followed by stomach (Ichihara 1975), lactating mammary gland (Cappuccino et al. 1978, De Santiago et al. 1998), heart, kidney, brain and skeletal muscle (Hutson 1988, Shinnick and Harper 1976). Adult rat liver does not contain either BCAT isoenzyme (Hall et al. 1993, Hutson et al. 1992).

The unique feature of the metabolism of BCAA in animals is its tissue specificity; most indispensable amino acids are degraded in the liver, whereas BCAA are metabolized extensively in extrahepatic tissues, where they are transported across the plasma membrane by a large neutral amino acid carrier system in almost all tissues including heart (Torres et al. 1995, Tovar et al. 1992), muscle (Tovar et al. 1991) and brain (Tovar et al. 1988). This characteristic pattern of BCAA catabolism is due to the specific tissue distribution of BCAT and the branched-chain alpha -keto acid dehydrogenase enzyme complex (Hutson et al. 1978, Shinnick and Harper 1976).

The high Km values reported for BCAT (0.4-4.91 mmol/L) (Davoodi et al. 1998, Hall et al. 1993, Ichihara et al. 1973, Taylor and Jenkins 1966) ensure that rates of catabolism of amino acids are low when tissue amino acid concentrations are low and high only when amino acid concentrations are elevated (Harper 1984b). BCATm, which is expressed in most tissues, is important in body nitrogen conservation due to its capacity to reaminate the branched-chain alpha -keto acids to form BCAA, thereby sparing nitrogen (Harper et al. 1984). Reported changes in BCAT activity in response to dietary and hormonal treatments of animals have been small and inconsistent (Harper et al. 1984, Ichihara et al. 1967, Mimura et al. 1968, Wohlhueter and Harper 1970). This study was conducted to clarify the effect of the protein content of the diet in well-nourished and protein-undernourished rats, and the effects of glucagon and hydrocortisone on the BCAT activity and mRNA concentration of the mitochondrial BCATm isoenzyme.

    MATERIALS AND METHODS
Abstract
Introduction
Methods
Results
Discussion
References

Animals and collection of tissues.  Male Wistar rats (70-90 g) were obtained from the Instituto Nacional de Nutrición (Mexico, D.F.). At the end of each study, rats were anesthetized with 30 mg/kg sodium pentobarbital before decapitation. Tissue samples used for RNA preparations were removed rapidly and frozen immediately in liquid nitrogen. These frozen tissue samples were stored at -80°C for <3 wk before isolation of total RNA. Tissue samples used for enzyme assays were removed and processed immediately. All experimental procedures using laboratory animals were approved by the Committee on Animal Research of the Instituto Nacional de Nutrición.

Diets.  The composition of the 0, 6, 10, standard 18, 35 and 50% casein powdered diets used in each of the different dietary treatment groups is shown in Table 1. The 6% casein diet was supplemented with 2 g/kg L-methionine and 4 g/kg L-threonine, at the expense of carbohydrate, to improve the nutritional quality of the dietary protein. With the exception of Experiment 2, all rats were allowed free access to the diets. All rats had free access to water throughout the study.

 
View this table:
[in this window] [in a new window]
 
Table 1. Composition of the diets containing different concentrations of protein

Experiment 1.  Male Wistar rats (80-90 g) were allowed free access to an 18% casein diet for 1 wk. Brain, heart, kidney, muscle, liver, lung, skin, stomach and intestine were removed, and a sample of each tissue was frozen immediately in liquid nitrogen for the determination of BCATm mRNA. A separate sample was used to measure BCAT activity.

Experiment 2.  Sixty male Wistar rats weighing 70-90 g were housed in individual stainless steel cages in air-conditioned rooms. The rooms were lighted from 0700 to 1900 h and dark from 1900 to 0700 h. Rats had free access to an 18% casein powdered diet for 1 d. Then, rats were divided into five groups of 12 rats each and fed a 0% (protein-free), 6% (low protein), 18% (control), 35 % (high protein) or 50% (high protein) casein diet. The five groups of rats were allowed free access to these diets for 4 d. To synchronize food intake, the rats were then trained to consume the diets in a restricted period of 7 h (0900-1600 h) for 10 d (i.e., 7 h feeding, 17 h food-deprivation). On d 10, three rats from each group were killed 3 and 6 h after they started eating their meal and after 5 and 17 h of food deprivation. Samples of liver, kidney, skeletal muscle, heart and brain were taken for the determination of BCATm mRNA levels and BCAT activity.

Experiment 3.  Twenty male Wistar rats weighing 80-90 g were allowed free access to a diet containing 0.5% casein for 5 wk (see Philbrick and Hill 1974). A pair-fed group (n = 5) was fed the same quantity of diet consumed by the group of malnourished rats, but the diet contained 18% casein. On d 36, five rats from the undernourished group and the pair-fed rats were killed. The remaining undernourished rats were divided into three groups of five rats each that were rehabilitated with diets containing 6, 18 or 50% casein for 21 d. All three groups of rats were killed on d 21. Samples of kidney, muscle and heart were obtained for measurement of BCAT activity and BCATm mRNA concentrations.

Experiment 4: hormone treatment.  Forty-eight male Wistar rats weighing between 75 and 90 g were fed a 10% casein diet for 7 d. The next day, rats were randomly divided into four groups of 12 rats each and subjected to one of the following treatments: 1) the hydrocortisone control group was injected subcutaneously with propylene glycol (100 µL/100 g body weight) twice a day for 7 d; 2) the hydrocortisone group was injected subcutaneously with hydrocortisone (1 mg/100 g body weight) twice a day for 7 d as described previously (Lee and Harper 1971, Lee et al. 1972, Morris et al. 1973); 3) the glucagon control group was injected intraperitoneally with saline (200 µL/100 g body weight) three times a day for 4 d; 4) the glucagon group was injected intraperitoneally with glucagon (0.2 mg/100 g body weight) three times a day for 4 d (Lee and Harper 1971, Lee et al. 1972, Morris et al. 1973). Groups 1 and 2 were killed at 0800 h on d 8, and groups 3 and 4 were killed at the same time on d 5. Kidney, muscle and heart were obtained for measurement of BCAT activity and BCATm mRNA concentration.

Tissue preparation and BCAT assay.  Tissues were removed, blotted and weighed. One gram of each tissue was used. Livers were homogenized in glass tissue grinders with a teflon pestle driven by an electric drill. Skeletal muscle, kidney, heart and brain were homogenized with a polytron homogenizer (Kinematica, AG, Luzerne, Switzerland) at the minimum setting. Before homogenization, all tissues were minced in 4 mL of mannitol-sucrose-EDTA medium containing 0.225 mol/L mannitol, 0.075 mol/L sucrose, 0.10 mmol/L EDTA and 5 mmol/L 3-(N-morpholino)propanesulfonic acid (MOPS), pH 7.0, containing 5 mmol/L benzamidine, 1 mmol/L disopropyl fluorophosphate, 1 mmol/L EDTA, 1mmol/L EGTA, 10 mg/L leupeptin, 5 mmol/L dithiothreitol and 10 mL/L Triton X-100. Tissue homogenates were centrifuged at 30,000 × g for 1 h at 4°C to obtain the supernatant fraction. The tissue extracts were kept at -80°C for 2 wk without loss of BCAT activity. Protein was determined by the biuret reaction in the presence of 2.5 mg/L sodium deoxycholate, with crystalline bovine albumin as standard.

BCAT activity was assayed in the extracts according to the method of Hutson et al. (1988) in small test tubes (10 × 45 mm) with a side arm (Wohlhueter and Harper 1970). Activity was measured at 37°C in 50 mmol/L potassium phosphate buffer, pH 7.8, which contained 50 µmol/L pyridoxal phosphate and 4 g/L3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS). The sample was introduced in a volume of 50 µL, and the reaction was initiated by the addition of the alpha -keto[1-14C]isocaproate (KIC)/isoleucine substrate mixture with a final concentration in the assay of 1.0 mmol/L [1-14C]KIC and 12 mmol/L isoleucine. After 5 min, the reaction was stopped by the addition of 500 µL of 2 mol/L sodium acetate, pH 3.4. The remaining [1-14C]KIC was removed by chemical decarboxylation by adding 250 µL of 30% hydrogen peroxide. The 14C-labeled leucine formed was quantified by addition of 250 µL of the reaction mixture to 10 mL of BCS liquid scintillation cocktail (Amersham, UK), and samples were counted in a Wallac scintillation counter (Turku, Finland). Each assay was conducted in duplicate. A unit of activity was defined as 1 µmol [1-14C]leucine formed/min at 37°C.

RNA preparation and Northern blot analysis.  Total RNA was isolated from tissues according to Chomczynski and Sacchi (1987). For Northern analysis, 20 µg of RNA was subjected to electrophoresis in a 1.5 % agarose gel containing 37% formaldehyde, transferred onto a nylon membrane filter (Hybond-N+, Amersham) and crosslinked with a UV crosslinker (Amersham). The probe was a 900-bp Pst1-Eco R1 fragment of the rat BCATm cDNA (Bledsoe et al. 1997). It was labeled with [alpha -32P]dCTP (110 TBq/mmol, Amersham) using the rediprime DNA labeling system (Amersham). Filters were prehybridized with rapid-hyb buffer (Amersham) at 65°C for 45 min, and then hybridized with the labeled probe for 2.5 h at 65°C. Membranes were washed once with 2X SSC (1X SSC = 150 mmol/L sodium chloride and 15 mmol/L sodium citrate)/0.1% SDS at room temperature for 20 min and then washed twice with 0.1X SSC/0.1% SDS at 65°C for 15 min each. An Instant Imager electronic autoradiography system (Packard Instrument, Meriden, CT) was used to produce digitized images for quantitation of radioactivity in the bands. Membranes were also exposed to Extascan film (Kodak, Guadalajara, Mexico) at -70°C with an intensifying screen.

Chemicals and reagents.  L-[1-14 C]Leucine and the nucleotide [alpha -32P]dCTP were obtained from Dupont NEN (Boston, MA). The radioactive KIC was synthesized from [1-14C]leucine as described by Rüdiger et al (1972). Hydrocortisone and glucagon were obtained from Sigma Chemical (St. Louis, MO) and Eli Lilly (Indianapolis, IN), respectively. All other reagents were from commercial sources and were at least reagent grade.

Statistics.  Differences among treatments were tested by one-way ANOVA and Fisher's protected least significant difference test (Stat View Version 4.02, Abacus Concepts, Berkeley, CA). Analysis of statistical differences in BCAT activity between dietary treatments and over time was done by two-way ANOVA. The effect of glucagon or hydrocortisone was analyzed by Student's t test. Differences were considered significant at P < 0.05.

    RESULTS
Abstract
Introduction
Methods
Results
Discussion
References

Experiment 1: BCATm mRNA and activity levels in rat tissues.  BCAT activity and BCATm mRNA concentration were measured in selected organs and tissues of rats 6 h after they consumed the standard 18% casein diet. Among the tissues assayed for enzyme activity, BCAT specific activity (mU/mg protein) was highest in stomach, intermediate in heart, brain, kidney, skin and muscle and low in lung and intestine (Fig. 1). BCAT activity has not been measured previously in skin. Interestingly, the specific activity of BCAT in this tissue was similar to values for skeletal muscle. Apparent BCAT activity was almost undetectable in liver. These results are in agreement with previous studies (Hall et al. 1993, Ichihara 1985). Although not strictly parallel, BCATm mRNA expression showed a pattern similar to that observed for BCAT activity (Fig. 1, Panel A). In agreement with the activity results, liver BCATm mRNA was undetectable by Northern analysis. The BCAT activity in brain is due to the expression of both the cytosolic and mitochondrial isoforms of the enzyme (Hall et al. 1993, Ichihara 1985) (see also Fig. 3).


View larger version (41K):
[in this window]
[in a new window]
 
Fig 1. Comparison of branched-chain aminotransferase (BCAT) activity and mitochondrial branched-chain aminotransferase (BCATm) mRNA levels in selected rat organs and tissues. Tissues were removed from rats fed a standard 18% casein diet 6 h after the initiation of feeding. Panel A: Northern blot analysis. Total RNA (20 µg) from each rat tissue was subjected to electrophoresis, blotted and hybridized with the uniformly 32P-labeled BCATm partial cDNA probe as described in Materials and Methods. Panel B: ethidium bromide staining of the gels used for Northern blot hybridization in Panel A. BCAT activity in mU/mg protein and in U/g tissue appears below each lane. A unit of activity is defined as 1 µmol leucine formed/min at 37°C. Values represent means ± SEM, n = 6 rats in each group.


View larger version (64K):
[in this window]
[in a new window]
 
Fig 3. Expression the mitochondrial branched-chain aminotransferase isoenzymes (BCAT) in muscle, heart, kidney and brain from rats fed different concentration of dietary protein. Panel A: Northern blot hybridization. Total RNA (20 µg) from each tissue was subjected to electrophoresis, blotted and hybridized with the 32P-labeled BCATm partial cDNA probe as described in Materials and Methods. In brain, the blots were also hybridized with the cDNA for BCATc, which gives a signal of ~2.7 kb. Panel B: ethidium bromide staining of the gels used for Northern blot hybridization of total RNA (20 µg per lane) for Northern blot hybridization. Panel C. BCATm mRNA concentrations. The levels of BCATm mRNA were estimated by densitometry (see Materials and Methods). Values for each tissue are means ± SEM, n = 3; values are expressed relative to the 18% casein group, which was set at 100% for each tissue. Bars with different letter superscripts are significantly different, P < 0.05.

Experiment 2: effect of dietary protein concentration on weight gain, BCAT activity and BCATm mRNA levels in rat tissues.  In this study, rats were divided into five groups that were allowed free access to diets containing 0, 6, 18 (control), 35 or 50% casein for 4 d. Food intake was then synchronized by restricting access to the diet to a period of 7 h. One day after the rats began receiving their respective diets on a restricted feeding schedule, they had lost weight. Rats fed the 18, 35 or 50% casein diets began to gain weight after 2 d of consuming their corresponding diet on the restricted feeding schedule. Rats fed a 6% casein diet began to gain weight after 4 d of being fed on the restricted feeding schedule, whereas rats fed the 0% casein diet lost weight continuously during the 10-d treatment period. At the end of the treatment period, the rates of weight gain were 5.6 ± 0.3, 5.9 ± 0.4 and 5.5 ± 0.3 g/d for the groups fed 18, 35 and 50% casein, respectively, and rates were not different among these groups. Rats fed the 6% casein diet had a significantly slower rate of weight gain (1.3 ± 0.09 g/d) than rats fed the 18% control diet. Rats fed the protein-free diet were losing weight at a rate of -1.4 ± 0.08 g/d.

The effect of meal-feeding and food deprivation on BCAT activity and BCATm mRNA levels in heart, liver, kidney, skeletal muscle and brain was determined during a 24-h period in rats adapted to consume their diet for 7 h (0900-1600 h). Tissues were removed from rats in each dietary group (0, 6, 18, 35 and 50% casein) at 3 and 6 h after receiving their respective diet, and after 5 and 17 h of food deprivation. The results from rats fed the 18% control diet are illustrated in Figure 2. As shown in Figure 2A, BCAT activity did not change significantly during the day in all tissues studied, indicating that there is no diurnal variation of BCAT activity. The same pattern was also observed in rats fed 0, 6, 35 or 50% casein diets (data not shown). BCATm mRNA concentrations in the tissues of rats fed an 18% casein diet (Fig. 2B), as well as in rats fed lower or higher protein concentrations (data not shown), also showed no significant variation throughout the day.


View larger version (38K):
[in this window]
[in a new window]
 
Fig 2. Diurnal changes in branched-chain aminotransferase (BCAT) activity and levels of the mitochondrial branched-chain aminotransferase (BCATm) mRNA in selected tissues from rats fed an 18% casein diet. Panel A: tissues were homogenized, extracted and assayed for BCAT activity as described in Materials and Methods. Values are means ± SEM, n = 3 rats at each time point (see Materials and Methods). Panel B: Northern blot hybridization. Total RNA (20 µg) from the same tissues as in Panel A was subjected to electrophoresis, blotted and hybridized with the 32P-labeled BCATm partial cDNA probe as described in Materials and Methods. Also shown on the right side of Panel B is ethidium bromide staining of the gels used for Northern blot hybridization.

To determine whether dietary protein affected activity and isoenzyme mRNA levels, BCAT activity (Table 2) and BCATm and BCATc mRNA levels (Fig. 3) were compared in the same tissues (liver, skeletal muscle, brain, kidney and heart) from rats killed 6 h after receiving their diets. There were significant effects of dietary protein concentration on skeletal muscle, brain and kidney BCAT activity. Skeletal muscle from rats fed the low protein 6% casein diet had lower BCAT activity than the other dietary groups, whereas in rats fed the 50% casein diet, activity was significantly higher than in the other groups. Skeletal muscle BCAT activity in rats fed the 0, 18 and 35% casein diets was similar. In the kidney, BCAT activity was higher in rats fed either a 35 or 50% casein diet than in rats fed lower levels of casein. Brains from rats fed the 50% casein diet had significantly higher BCAT activity than the other groups. BCAT activity in heart was not affected by dietary protein concentration. These results indicate that a high protein diet resulted in higher levels of BCAT activity in all tissues except heart with increases ranging from 15 to 48%. Significant differences in apparent transaminase activity among some dietary groups were found in liver, but there was no consistent effect of dietary protein on this activity.

 
View this table:
[in this window] [in a new window]
 
Table 2. Branched-chain aminotransferase (BCAT) activity in rat liver, skeletal muscle, brain, kidney and heart from rats fed different concentrations of dietary protein1,2

Northern blots of BCATm mRNA from kidney, heart, muscle and brain of rats fed different concentrations of protein are shown in Figure 3. BCATm mRNA expression was not detected in livers of any of the rats (data not shown). There were no significant differences in the expression of BCATm mRNA in heart, kidney and brain of rats fed different concentrations of dietary protein. In agreement with previous reports (Hall et al. 1993, Hutson et al 1995), both BCATc and BCATm mRNAs were expressed in brain; however, neither message was influenced by dietary protein concentration. Muscle BCATm mRNA expression was greater in rats fed a protein-free diet or a 50% casein diet than in those fed 6, 18 or 35% casein.

Experiment 3: effect of protein rehabilitation in malnourished rats on body weight, BCAT activity and BCATm mRNA levels in rat tissues.  After 5 wk of consuming a diet containing 0.5% casein, rats did not gain weight but had actually lost 39% of their initial body weight (Table 3). Rats pair-fed an 18% casein diet did not lose weight; however, their weight had increased by only 11 g (12.5% increase) at the end of 5 wk. Nevertheless, the pair-fed group weighed significantly more than the 0.5% casein group (P < 0.05). In comparison, animals that had free access to the standard 18% casein diet gained 216 g during the same period. Thus growth, as measured by weight gain, was stunted in both the protein-malnourished (0.5% casein) and the pair-fed group. After 21 d of rehabilitation therapy with 6, 18 or 50% casein diets, rats fed a 6% casein diet had gained weight (16% increase). Rats rehabilitated with diets containing 18 or 50% casein had increased their body weights by 213 and 245%, respectively, during the same period of time (Table 3).

 
View this table:
[in this window] [in a new window]
 
Table 3. Effect on body weight of feeding rats a 0.5% casein diet followed by rehabilitation with diets containing 6, 18 or 50% casein1

BCAT activity in kidney, muscle and heart of protein-malnourished rats (0.5% casein diet) did not differ from rats with free access to an 18% casein diet or to the pair fed group (Table 4). Compared with protein-malnourished rats, there was no effect on BCAT activity in any of the tissues in rats that underwent protein rehabilitation for 21 d with a 6 or 18% casein diet, whereas rehabilitation with a 50% casein diet resulted in significantly higher BCAT activity (81%) in muscle (Table 4). BCATm mRNA levels in kidney and heart were similar in all experimental groups (data not shown). Consistent with the higher levels of BCAT activity in skeletal muscle of rats rehabilitated with 50% casein, skeletal muscle BCATm mRNA levels were higher in this group than in the malnourished, pair-fed, control 18% and 6 or 18% rehabilitated groups (Fig. 4).

 
View this table:
[in this window] [in a new window]
 
Table 4. Branched-chain aminotransferase (BCAT) activity in tissues from protein-malnourished rats and rats rehabilitated with diets containing 6, 18 or 50% casein1


View larger version (34K):
[in this window]
[in a new window]
 
Fig 4. Effect of protein rehabilitation of malnourished rats (PM) with diets containing 6, 18 or 50% casein on skeletal muscle BCATm mRNA levels. Malnourished rats had free access to a 0.5% casein diet for 5 wk (PM). Pair-fed (PF) rats were fed the same quantity of an 18% casein diet as consumed by the PM group. Rats (FA) had free access to an 18% casein diet. Rats were rehabilitated with 6,18 or 50% casein diets for 21 d. Values are means ± SEM, n = 5; values are expressed relative to the FA group, which was arbitrarily set at 100% Bars with different letter superscripts are significantly different, P < 0.05.

Experiment 4: hormonal treatments.  In comparison with the group injected with the vehicle solution, treatment of rats with hydrocortisone or glucagon for several days did not affect BCAT activity significantly in muscle, heart or kidney. For example, in skeletal muscle, values for control and hydrocortisone-injected rats were 9.1 ± 0.8 and 9.3 ±1.0 mU/mg protein, respectively, whereas the control and glucagon-injected rat muscle BCAT activities were 8.1 ± 0.7 and 9.3 ± 0.5 mU/mg protein, respectively. There were also no differences in the BCATm mRNA levels in these tissues (data not shown).

    DISCUSSION
Abstract
Introduction
Methods
Results
Discussion
References

The BCAA comprise ~20% of the total amino acids of tissue protein and ~35% of the indispensable amino acids in muscle. They also make up ~40% of the indispensable amino acid requirement of young rapidly growing animals including humans (Harper et al. 1983). Therefore, catabolism of BCAA must be regulated to maintain adequate levels of BCAA to meet the requirements for growth in younger animals and maintenance in adult animals. Most nutritional studies have focused on the effect of diet and hormones on the mitochondrial branched alpha -keto acid dehydrogenase, the second enzyme in the catabolic pathway. The activity state of this enzyme in liver is increased by the ingestion of a high protein diet (Crowell et al. 1988, Miller et al. 1988, Wohlhueter and Harper 1970, Zhao et al. 1994).

In this study, we have examined the effect of diet on levels of BCAT activity and expression of the mitochondrial BCATm isoenzyme in rat tissues. A BCATm message of 1.7 kb, corresponding to the mitochondrial form of BCAT (Bledsoe et al. 1997), was observed in all tissues except liver. These results confirm and extend previous reports (Bledsoe et al. 1997, Hutson et al. 1992). The highest BCATm mRNA concentration was found in stomach, which also had the highest BCAT activity. The distribution of BCATm mRNA observed in most of the tissues was in agreement with the published pattern of BCAT activity (see Fig. 1; Cappuccino et al. 1978, Goto et al. 1977, Hall et al. 1993, Hutson 1988, Ichihara 1975). We have demonstrated for the first time the presence of BCATm in skin and lung tissue. The current model of BCAA metabolism predicts that there is extensive transamination of BCAA in skeletal muscle and oxidation of the alpha -keto acid products in liver (Harper et al. 1984, Hutson et al. 1978). In this model, BCAA are thought to play a critical role in body nitrogen metabolism. Our results suggest that BCAA transamination may serve additional functions in other tissues such as skin; for example, it has been reported that BCAA are precursors of branched long-chain fatty acids found in rat skin surface lipid (Oku et al. 1994). The extent to which BCAA are oxidized in tissues such as skin or lung remains to be determined.

We did not observe significant oscillations in rat tissue BCAT activity during the day regardless of the concentration of the protein in the diet. BCATm mRNA levels were also unaffected by dietary protein concentration in all tissues except muscle. It has been demonstrated that changes in enzyme concentration as well as mRNA concentration are dependent on their rates of synthesis and degradation. Therefore, proteins or mRNAs with rapid rates of turnover will respond rapidly to environmental changes, whereas those with slow rates of turnover will respond slowly (Berlin and Schimke 1965). The half-lives for the hepatic amino acid-degrading enzymes are in the range of 2-3 h up to 2.5 d (Schimke 1970). Unpublished results from our laboratory have shown that the half-life of BCATm under different physiologic conditions is ~4.5 d. Thus the dietary treatments were of sufficient duration to detect changes in gene expression and BCATm protein levels.

Contradictory results have been reported in studies that have examined only BCAT activity in kidney and muscle of rats fed high protein diets (Chan and Walser 1978, Ichihara et al. 1967, Mimura et al. 1968, Wohlhueter and Harper 1970). In skeletal muscle, a high protein intake resulted in a modest increase in BCAT activity in rats in the study by Mimura et al. (1968), and no change in rats fed diets containing between 0 and 18% casein in the study by Chan and Walser (1978). We measured BCATm expression and BCAT activity in this study and showed clearly (Table 4, Fig. 3) that high protein intake regulated expression and activity exclusively in muscle. These results suggest that the effect of dietary protein is tissue specific because the increments in BCAT activity in kidney and brain produced by the consumption of a high protein diet were unrelated to changes in BCATm mRNA levels.

It has been shown that rats starved for 1 d had increased BCAT activity in muscle, although prolonged starvation up to 5 d did not produce a further increase in BCAT activity (Adibi et al. 1975). In our study, BCAT activity, as well as BCATm mRNA concentrations, in muscle of malnourished rats was similar to that of rats with free access to the 18% casein diet. These results are in agreement with a previous study that indicated that BCAT activity is unaffected by protein malnutrition (Reeds 1974). However, rehabilitation of malnourished rats with a 50% casein diet did increase BCAT activity and BCATm mRNA expression in muscle. Studies with other hepatic or serum aminotransferases have shown that their activities are increased during malnutrition (Heard et al. 1977, Osifo and Bolodeoku 1982), suggesting that control of the expression of these enzymes is different from that of BCAT, which is an extrahepatic enzyme.

High protein diets produce an increase in the activities of liver amino acid-degrading enzymes to catabolize the excess amino acids (Harper 1984a), and the change in activity of most of these enzymes is associated with an increase in the rate of transcription of their genes (Ogawa et al. 1991, Torres et al. 1998). In this study, the increase in muscle BCATm mRNA concentration due to the consumption of a high protein diet could be explained by an increase in the rate of transcription of the BCAT gene, or by a decrease in the rate of degradation of its mRNA.

Several of the hepatic amino acid-degrading enzymes are induced by hormones such as glucagon or glucocorticoids. Previous reports have shown that hydrocortisone injection produced small changes (Mimura et al. 1968) or no change (Ichihara et al. 1967) in BCAT activity in muscle. We found no effect of hydrocortisone or glucagon injection on BCAT activity or BCATm mRNA concentrations, suggesting that the promoter region of the BCATm gene probably lacks glucocorticoid and glucagon hormone-specific responsive elements. Furthermore, because it has been reported that glucagon and glucocorticoid levels increase during food deprivation (Lunn et al. 1973), which in turn stimulates the activity of several hepatic amino acid-degrading enzymes, it is clear that the mechanisms of regulation of the hepatic and extrahepatic amino acid-degrading enzymes are different.

Finally, our study is consistent with the hypothesis that muscle BCATm is involved in the removal of excess BCAA after the consumption of a high protein diet. However, in situations in which there is a need to conserve amino acids such as in malnutrition, BCAT activity and BCATm mRNA levels are preserved. These results indicate that the BCAA and BCAA transamination must serve an additional function in body metabolism that prevents them from being down-regulated when the indispensable amino acid supply is limited.

    FOOTNOTES
1   Supported by the National Council of Science and Technology (CONACYT) 1098-M9201 (N.T.), México and DK 34733 (S.M.H).
2   The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
3   To whom correspondence should be addressed.
4   Abbreviations used: BCAA, branched-chain amino acids; BCAT, branched-chain aminotransferase; BCATm, mitochondrial branched-chain aminotransferase; BCATc, cytosolic branched-chain aminotransferase; KIC, alpha -ketoisocaproate; MOPS, 3-(N-morpholino)propanesulfonic acid.

Manuscript received 4 December 1997. Initial reviews completed 29 January 1998. Revision accepted 3 April 1998.

    LITERATURE CITED
Abstract
Introduction
Methods
Results
Discussion
References

0022-3166/98 $3.00 ©1998 American Society for Nutritional Sciences



This article has been cited by other articles:


Home page
J. Nutr.Home page
S. C. Kalhan and P. S. Parimi
Transamination of Leucine and Nitrogen Accretion in Human Pregnancy and the Newborn Infant
J. Nutr., January 1, 2006; 136(1): 281S - 287S.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
D. W. Dean, L. L. Southern, B. J. Kerr, and T. D. Bidner
Isoleucine requirement of 80- to 120-kilogram barrows fed corn-soybean meal or corn-blood cell diets
J Anim Sci, November 1, 2005; 83(11): 2543 - 2553.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. R. Tovar, C. Ascencio, and N. Torres
Soy protein, casein, and zein regulate histidase gene expression by modulating serum glucagon
Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1016 - E1022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. J. Lynch, S. M. Hutson, B. J. Patson, A. Vaval, and T. C. Vary
Tissue-specific effects of chronic dietary leucine and norleucine supplementation on protein synthesis in rats
Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E824 - E835.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Morens, C. Gaudichon, G. Fromentin, A. Marsset-Baglieri, A. Bensaid, C. Larue-Achagiotis, C. Luengo, and D. Tome
Daily delivery of dietary nitrogen to the periphery is stable in rats adapted to increased protein intake
Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E826 - E836.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Faure, F. Glomot, and I. Papet
Branched-Chain Amino Acid Aminotransferase Activity Decreases during Development in Skeletal Muscles of Sheep
J. Nutr., May 1, 2001; 131(5): 1528 - 1534.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. R. Tovar, E. Becerril, R. Hernandez-Pando, G. Lopez, A. Suryawan, S. Desantiago, S. M. Hutson, and N. Torres
Localization and expression of BCAT during pregnancy and lactation in the rat mammary gland
Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E480 - E488.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J.-H. Yuan, A. J. Davis, and R. E. Austic
Temporal Response of Hepatic Threonine Dehydrogenase in Chickens to the Initial Consumption of a Threonine-Imbalanced Diet
J. Nutr., November 1, 2000; 130(11): 2746 - 2752.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Morens, C. Gaudichon, C. C. Metges, G. Fromentin, A. Baglieri, P. C. Even, J.-F. Huneau, and D. Tomé
A High-Protein Meal Exceeds Anabolic and Catabolic Capacities in Rats Adapted to a Normal Protein Diet
J. Nutr., September 1, 2000; 130(9): 2312 - 2321.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torres, N.
Right arrow Articles by Tovar, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torres, N.
Right arrow Articles by Tovar, A. R.